Aktis Oncology, Inc. company logo
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock Beta

Beta

3.980.08+2.05%

Summary

Current Value
As of today, AKTS beta is 3.98, up +2.05% on
Current Value Category
Based on its current beta, AKTS falls into the high volatility category
1-Year High
AKTS beta reached a 1-year high of 4.35 on
1-Year Low
AKTS beta reached a 1-year low of -2.94 on

Beta Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AKTS Performance
MetricDateValue1D1M3MYTD1Y3Y5Y
Beta3.98+2.0%
Price$19.64-4.2%
SPX6,963.44-0.2%+0.8%+1.1%+1.7%+15.3%+71.1%+87.5%
200-Day SMA$20.92-0.5%
50-Day SMA$20.92-0.5%
14-Day RSI35.99-12.8%
ATR$1.56+1.2%
10-Day Volatility84.44%+2.0%
1-Month Volatility74.49%-2.0%
1-Year Volatility74.49%-2.0%

Beta History

DateValueChange
3.98-

FAQ

  • What is the current beta of AKTS?

    As of today, AKTS beta is 3.98

  • What beta category does AKTS fall into?

    Based on its current beta, AKTS falls into the high volatility category

  • What is AKTS beta 1-year high?

    AKTS beta reached a 1-year high of 4.35 on January 22, 2026

  • What is AKTS beta 1-year low?

    AKTS beta reached a 1-year low of -2.94 on January 13, 2026

Data Sources & References

  1. AKTS Official Website www.aktisoncology.com
  2. AKTS Profile on Yahoo Finance finance.yahoo.com/quote/AKTS
  3. AKTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/akts